Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 4 Univariate analyses for overall survival in metastatic gastric cancer patients who underwent surgery (n = 83)

From: Identification of prognostic factors and surgical indications for metastatic gastric cancer

Variable Median survival (months) p value
Age (years)   0.269
  >65 16.0  
  < 65 15.6  
Sex   0.211
  Male 16.6  
  Female 11.1  
Body mass index (kg/m2)   0.647
  >21 17.2  
  < 21 14.2  
Hb (g/dL)   0.423
  >12 17.2  
  < 12 14.4  
NLR   < 0.001
  >3.1 21.9  
  < 3.1 11.1  
CRP (mg/dL)   0.016
  >0.2 11.1  
  < 0.2 17.2  
Alb (g/dL)   0.001
  >3.5 17.7  
  < 3.5 9.8  
CEA (ng/mL)   0.022
  ≤ 6 16.8  
  >6 13.4  
CA19-9 (U/mL)   0.001
  ≤ 37 17.7  
  >37 10.1  
Tumor location in stomach   0.426
  Upper 16.2  
  Middle 15.6  
  Lower 16.0  
  Whole 13.1  
Adjacent organ invasion   0.364
  Yes 13.1  
  No 16.2  
Bulky lymph nodes   0.149
  Yes 13.4  
  No 17.7  
Histological differentiation   0.404
  Differentiated 16.0  
  Undifferentiated 15.6  
Metastasis to organs   0.078
  1 organ 17.7  
  ≥2 organs 14.2  
Peritoneal metastasis   0.213
  Yes 12.5  
  No 17.7  
Hepatic metastasis   0.784
  Yes 16.5  
  No 14.4  
Distant lymph node metastasis   0.973
  Yes 14.9  
  No 16.5  
Surgical procedure   0.017
  Gastrectomy 12.5  
  Gastrectomy + metastasectomy 21.9  
Chemotherapy   0.015
  Yes 16.6  
  No 8.2